Blue Genes Lab, a leading pharmacogenetics (PGx) provider with a groundbreaking approach to using genetic data to protect patients and reduce costs for payers at the moment it matters, today announced that it has been endorsed by the New York Labor Health Care Alliance (NYLHCA) for use by its 79 member unions representing 150,000 members and dependents.
TopDoctor Magazine sat down with Blue Genes CEO Nick Glimcher to talk about why so many genetic results never make it from the chart to the prescription, and what it takes to change that.